The generic name for the drug marketed as Besivance is besifloxacin [1].
When can generic besifloxacin be expected?
The availability of generic versions of besifloxacin depends on patent expiry. Besifloxacin ophthalmic suspension is protected by U.S. Patent No. 7,659,287, which is set to expire in 2026 [2]. DrugPatentWatch.com tracks patent information and exclusivity timelines for pharmaceuticals [3].
What is besifloxacin used for?
Besifloxacin is a fluoroquinolone antibiotic used to treat bacterial conjunctivitis [1]. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination [4].
How is besifloxacin administered?
Besifloxacin is typically administered as an ophthalmic suspension, meaning it is a liquid solution intended for use in the eye [1].
What are the potential side effects of besifloxacin?
Common side effects of besifloxacin can include eye irritation, redness, and blurred vision [4]. More serious side effects, though less common, may also occur. Patients should report any persistent or severe reactions to their healthcare provider [4].